IU School of Medicine research findings provide advances in treatment of triple negative breast cancer
Harborside • The Nexus of Knowledge
Journal of Clinical Oncology (@JCO_ASCO) / Twitter
2021 ASCO Breast Cancer Abstracts | Journal of Clinical Oncology
Disparities in breast cancer care linked to n | EurekAlert!
Clinical Diagnosis and Management of Breast Cancer | Journal of Nuclear Medicine
Postmastectomy and Regional Nodal Radiation for Breast Cancer | Journal of Clinical Oncology
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Oncoplastic Surgery in the Management of Breast Cancer | Journal of Clinical Oncology
Progression-free survival and time to progression as primary end points in advanced breast cancer: often used, sometimes loosely defined. | Semantic Scholar
Abemaciclib combined with endocrine therapy for the adjuvant treatment of hr+, her2-, node-positive, high-risk, early breast cancer (monarche)
PDF) Breast cancer. Clinical practice guidelines in oncology | Ingrid Mayer - Academia.edu
Journal of Clinical Oncology Archives - Agendia Inc.
Journal of Clinical Oncology :
Challenges of Creating New Tumor-Infiltrating Lymphocyte for Combating Breast Cancer | Journal of Clinical Oncology
Korean Journal of Clinical Oncology
Korean Journal of Clinical Oncology
VisualAbstract: Adjuvant capecitabine improves long-term survival in early breast cancer | 2 Minute Medicine
HER2-Low Breast Cancer: Pathological and Clinical Landscape | Journal of Clinical Oncology
International Journal of Clinical Oncology 1/2017 | springermedizin.de
Next-Generation Endocrine Therapies for Breast Cancer | Journal of Clinical Oncology
Athenex Announces Publication of Data from Phase 3 Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients with Metastatic Breast Cancer in the Journal of Clinical Oncology
JOURNAL OF CLINICAL ONCOLOGY 25: - ppt download
Publications - International Breast Cancer Center
Paolo Tarantino on Twitter: "In June 2020, an issue of JCO was published, including the first data of T-DXd in HER2-low MBC & the first review on this entity (https://t.co/peW12yxzPp) 2 years
Syapse - A study in the Journal of Clinical Oncology concludes increasing access to germline genetic testing could expand clinicians' ability to apply precision treatments and personalize risk assessment for breast cancer
Clinical Breast Cancer impact factor and citations:... | Exaly
Home Page: Clinical Breast Cancer
Home - Chinese Clinical Oncology
